Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Guus Van Scharrenburg"'
Autor:
Esther Strating, Sjoerd Elias, Guus van Scharrenburg, Kaisa Luoto, André Verheem, Inne Borel Rinkes, Herman Steen, Onno Kranenburg
Publikováno v:
Cancers; Volume 14; Issue 18; Pages: 4348
Peritoneal metastases in colorectal cancer (CRC) belong to Consensus Molecular Subtype 4 (CMS4) and are associated with poor prognosis. Conventional imaging modalities, such as Computed Tomography (CT) and Fluorodeoxyglucose-Positron Emission Tomogra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9b4bd62963f14e1b957879079692a9d
Autor:
Herman Steen, Irina Velikyan, Gunnar Antoni, Guus Van Scharrenburg, Johan G. Doverfjord, Sergio Estrada
Publikováno v:
Nuclear Medicine and Biology. :73-85
Introduction: Early detection of liver fibrosis and monitoring response to treatment crucial for the management of patients are currently not feasible in clinical practice. Platelet derived growth factor receptor beta (PDGER-beta) expression is regar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6e2eeef6a0dc01a35d2f0d95787691
https://doi.org/10.1016/j.nucmedbio.2020.07.009
https://doi.org/10.1016/j.nucmedbio.2020.07.009
Autor:
Irina, Velikyan, Johan G, Doverfjord, Sergio, Estrada, Herman, Steen, Guus, Van Scharrenburg, Gunnar, Antoni
Publikováno v:
Nuclear medicine and biology.
Early detection of liver fibrosis and monitoring response to treatment crucial for the management of patients are currently not feasible in clinical practice. Platelet derived growth factor receptor β (PDGFR-β) expression is regarded as a potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::daf5ebecae3254bf3da1d96cf8416929
https://pubmed.ncbi.nlm.nih.gov/32805638
https://pubmed.ncbi.nlm.nih.gov/32805638
Autor:
Juliana, Bronzova, Cristina, Sampaio, Robert A, Hauser, Anthony E, Lang, Olivier, Rascol, Ad, Theeuwes, Serge V, van de Witte, Guus, van Scharrenburg, S, Moskovko
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 25(6)
This study examined the efficacy and safety of the partial dopamine agonist, pardoprunox (SLV308), in the treatment of patients with early Parkinson's disease (PD). Patients were randomized to receive pardoprunox (n = 69) or placebo (n = 70). Pardopr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::29957a9d7ed5025079c1dedcb5baeecc
https://pubmed.ncbi.nlm.nih.gov/20198713
https://pubmed.ncbi.nlm.nih.gov/20198713
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Biomembranes. 731:448-455
1-Palmitoyllysophosphatidylcholine has been mixed in equimolar amounts with specifically deuterated palmitic acid and the structural properties of the lipid/water phase have been studied by 2H- and 31P-nuclear magnetic resonance. The order profile of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::902f1e0efd0e96ca80ced1d4173c88e5
https://doi.org/10.1016/0005-2736(83)90040-8
https://doi.org/10.1016/0005-2736(83)90040-8
Publikováno v:
European journal of biochemistry. 110(1)
Antisera were raised against the purified Escherichia coli K12 outer membrane proteins ompA-, ompC- and ompF proteins and protein e. Several immunological methods were used to investigate the specificity of the antisera and the immunological relation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93daac24af6b961a5febacea0b1c0da8
https://pubmed.ncbi.nlm.nih.gov/7002546
https://pubmed.ncbi.nlm.nih.gov/7002546